GLP-1 RAs are a class of diabetes medication that includes drugs like Trulicity, Ozempic, and Byetta. Drugs in this class have been shown to have a beneficial effect on heart health. Researchers examined whether GLP-1 RAs’ effectiveness in reducing blood glucose (HbA1c) levels is responsible for the reduction in cardiovascular risk associated with the medications. […]
Time-restricted eating refers to a diet plan in which eating is restricted to a specific period of time during the day. Researchers say time-restricted eating may be able to help people with type 2 diabetes reduce nocturnal hypertension. Elevated blood pressure during the night has been linked to increased cardiovascular risk. Read more
HbA1c variability — changes in blood glucose levels and swings between hypo- and hyperglycemia — can increase the risk of developing cardiovascular disease. Often, glucose variability is associated with poor diabetes management, which can contribute to poor heart health. Read more
Creating treatment interventions that made diabetes management more like a game helped patients who had diabetes and overweight or obesity improve their physical activity levels, researchers found, although it did not seem to help them manage their blood glucose or lose weight. Read more
In people who do not have diabetes, the hormone amylin is secreted in the pancreas alongside insulin, and people with diabetes lack both insulin and amylin. Do artificial pancreas systems perform more effectively when pramlintide, a medication that is an analog of amylin, is added to them? Read more
A popular drug type, proton pump inhibitors (PPIs), that is used to treat heartburn and stomach ulcers has been found to improve blood sugar control in patients with diabetes when used in addition to their usual treatment. These drugs do not prevent diabetes in people who do not already have the condition, the researchers say. […]
The US Food and Drug Administration (FDA) recently approved a 2.4 mg/week subcutaneous dose of the GLP-1 receptor agonist semaglutide for weight loss in people who have obesity, or overweight with a related health complication. Semaglutide is already in use to treat type 2 diabetes, but the approval for this drug, to be sold under […]
Soaring summer temperatures can make anyone sluggish and uncomfortable, especially when accompanied by high humidity. But people with diabetes may be at greater risk for some negative effects of hot weather. One example is that people with diabetes tend to more easily suffer from dehydration. Read more
Tirzepatide, a new once-weekly GIP/GLP-1 medication, is now in phase 3 testing for blood glucose management and chronic weight management in individuals with type 2 diabetes. GIP is a hormone that may help GLP-1 receptor agonists work better, and has been found in early testing to reduce food intake while increasing energy expenditure, resulting in […]
Scientists are still investigating ongoing health issues in those who have recovered from COVID-19. Now, new research suggests that COVID-19 may damage the pancreas, and thus cause diabetes. The virus attacks and damages cells within the body, including cells that are critical in preventing diabetes. Read more
Obesity is linked to an increased risk of developing cardiovascular disease (CVD), as well as type 2 diabetes. A recent study examined whether bariatric surgery could reduce the risk of cardiovascular disease in patients who have diabetes and obesity. Read more
The American Diabetes Association (ADA) has updated its Standards of Medical Care in Diabetes guidelines with recent data from clinical trials. The trials investigated cardiovascular disease and chronic kidney disease in type 2 diabetes and delay of type 1 diabetes. Read more
A study found that the development of type 2 diabetes was reduced by 32% in participants who took the SGLT-2 inhibitor medication dapagliflozin instead of placebo, suggesting there may be a possible prevention, as well as treatment, role for this diabetes drug. Read more
Teenagers with overweight or obesity may be more likely to develop type 2 diabetes or have a heart attack when they reach their 30s and 40s, even if they lose weight in adulthood, a recent study says. Read more
Previous research has found there tends to be a decrease in gut flora in patients with prediabetes and T2DM compared to people without these conditions. A recent study suggests that probiotic supplementation with certain strains of naturally occurring gut bacteria may help improve glucose control in patients with type 2 diabetes. Read more
For the first time, the American Association of Clinical Endocrinology (AACE) has issued official guidelines on the use of advanced technologies in the treatment of people with diabetes. The guidelines include recommendations for the use of technologies such as continuous glucose monitoring (CGM), insulin pumps, connected pens, automated insulin delivery systems, telemedicine, and smartphone apps. […]
Exercise is an important component of maintaining good health, particularly for people with diabetes. Some of us find it harder to exercise as we grow older and our bodies change, but maintaining a good exercise program is even more important to keep our bodies strong and support independent living. Diabetes exercise expert Dr. Sheri Colberg […]
The percentage of US adults with diabetes who achieved glycemic control declined from 2007 to 2010, and again between 2015 and 2018, decreasing from 57.4% in 2007 to 50.5% in 2018, researchers say. Read more
While insulin therapy reduces the overall incidence of diabetic retinopathy and other diabetic complications, intensive insulin therapy with rapid glycemic reduction could actually worsen retinopathy progression in some patients. Healthcare professionals should assess patient’s current retinopathy status before selecting the type of insulin and intensiveness of treatment. Read more
Researchers say that reducing the amount of branched-chain amino acids (BCAAs) in the diet could help reduce type 2 diabetes and obesity. While some athletes use BCAAs to improve their performance, the researchers say that in more sedentary people, particularly those at risk of obesity or diabetes, reducing BCAAs could promote better health. Read more